How to proceed with an active ingredient that can be effective...
Although numerous clinical trials are underway, there is currently no evidence from controlled clinical trials to recommend...
Events and news
BlogRegulatory Affairs
April 22, 2020
Although numerous clinical trials are underway, there is currently no evidence from controlled clinical trials to recommend...
Regulatory Affairs
December 9, 2019
Positioned as the second largest pharmaceutical market in the world and showing a steady and extensive growth pattern, Europe’s...
Regulatory Affairs
November 27, 2019
What are Advanced Therapies? Advanced-therapy medicines are medicines that are made from genes and cells. They may offer...
Regulatory Affairs
November 27, 2019
In recent years, the volume of generic drug sales has been increasing rapidly in Europe, whereas the outsourcing of branded...
Regulatory Affairs
November 27, 2019
The action plan developed by the AEMPS and published April 2016 focuses on the set up of specific activities, such as the...
Regulatory Affairs
November 21, 2019
The European pharma market is becoming more competitive and accessible through its effort to adopt globally acknowledged...
Regulatory Affairs
November 20, 2019
On 29 March 2017, the United Kingdom notified the European Council of its intention to withdraw from the European Union,...
Over 100 professionals
Over 500 clients
9 years of experience
Leading innovation
100% client oriented